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Supplemental Figure 1: Radiation exposure induces the cell-surface expression of Galectin-1 in 
endothelial cells. Expression profile of Galectin-1 after increasing dose 0.5-4 Gy of radiation exposure in the 
membranous fractions of various endothelial cell types [EA.hy926, Endothelial Progenitor cells (EPC) and 
HUVEC] and the human breast cancer cell line (MDA-MB231). The blots were reprobed of GAPDH to assess 
equal loading. 
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Supplemental Figure 2: Schematic of regulation of galectin-1 in tumor/ tumor microenvironment. (A) 
Under the hypoxic conditions in the tumor, galectin-1 increase is regulated by elevated levels of HIF-1 in the 
tumor cells and factors secreted by the tumor cells and the endothelial cell specific transcription factor Egr-1 in 
the endothelial cells. (B) Radiation exposure of the tumors causes release of stress factors that trigger the 
production of HIF-1 and Egr-1 which in turn result in a further increase in galectin-1. 
 
 
